Document Detail

Effect of beta blockers, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, and statins on mortality in patients with implantable cardioverter-defibrillators.
MedLine Citation:
PMID:  18572039     Owner:  NLM     Status:  MEDLINE    
Nine hundred sixty-five patients (mean age 70 years) with implantable cardioverter-defibrillator were followed for 32 +/- 33 months for all-cause mortality. Death occurred in 73 of 515 patients (13%) treated with beta blockers (group 1), in 84 of 494 patients (17%) treated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers (group 2), in 56 of 402 patients (14%) treated with statins (group 3), in 40 of 227 patients (18%) treated with amiodarone (group 4), in 5 of 26 patients (19%) treated with sotalol (group 5), and in 64 of 265 patients (24%) treated with no beta blocker, angiotensin-converting enzyme inhibitor or angiotensin receptor blocker, statin, amiodarone, or sotalol (group 6) (p <0.001 for group 1 vs group 6 and group 3 vs group 6, p <0.02 for group 2 vs group 6). In conclusion, patients with implantable cardioverter-defibrillators should be treated with beta blockers, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, and statins to reduce mortality.
Hoang M Lai; Wilbert S Aronow; Adam Kruger; Harit Desai; Harshad Amin; William H Frishman; Martin Cohen; Carmine Sorbera
Related Documents :
22357119 - Effects of freezing on the bactericidal activity of human milk.
8743519 - Nitrendipine and enalapril in the treatment of diabetic hypertensive patients with micr...
15708179 - Impact of medical treatment on lung diffusion capacity in elderly patients with heart f...
9581729 - Combined oral positive inotropic and beta-blocker therapy for treatment of refractory c...
8500859 - Captopril or conventional therapy in hypertensive type ii diabetics. three-year analysis.
8061849 - Changes in left ventricular dimensions and haemodynamics during antihypertensive treatm...
18055659 - Propofol sedation: intensivists' experience with 7304 cases in a children's hospital.
12781889 - A prospective controlled double-blind trial of great auricular nerve preservation at pa...
22584629 - The effect of prophylactic transpapillary pancreatic stent insertion on clinically sign...
Publication Detail:
Type:  Journal Article     Date:  2008-04-22
Journal Detail:
Title:  The American journal of cardiology     Volume:  102     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  2008 Jul 
Date Detail:
Created Date:  2008-06-23     Completed Date:  2008-08-12     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  77-8     Citation Subset:  AIM; IM    
Department of Medicine, Cardiology Division, New York Medical College, Valhalla, NY, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adrenergic beta-Antagonists / therapeutic use*
Aged, 80 and over
Angiotensin II Type 1 Receptor Blockers / therapeutic use*
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
Cardiomyopathies / mortality*,  therapy
Defibrillators, Implantable / adverse effects*
Follow-Up Studies
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Myocardial Ischemia / mortality*,  therapy
Retrospective Studies
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Angiotensin II Type 1 Receptor Blockers; 0/Angiotensin-Converting Enzyme Inhibitors; 0/Hydroxymethylglutaryl-CoA Reductase Inhibitors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Usefulness of left atrial volume index to predict heart failure hospitalization and mortality in amb...
Next Document:  Comparison of one-year outcome (death and rehospitalization) in hospitalized heart failure patients ...